Health Condition 1: R418- Other symptoms and signs involvingcognitive functions and awareness
Conditions
Interventions
None listed
Sponsors
National Institute of Ayurveda, Deemed to be University, Jaipur
Eligibility
Inclusion criteria
Inclusion criteria: 1. Pharmacological or non-pharmacological interventions specifically targeting cognitive function Participants aged 40-70 years. 2. Individuals diagnosed with mild cognitive impairment (MCI) based on established DSM-5 TR (Diagnostic and Statistical Manual of Mental Disorders – 5th edition – Text Revision) diagnostic criteria. 3. Participants who are willing and able to provide informed consent to participate in the study. 4. Participants who are willing to comply with the study procedures and attend scheduled follow-up visits. 5. Participants with a stable medical condition that allows them to participate in the study without significant interference. 6. Participants who are not currently receiving any other pharmacological or non- pharmacological interventions specifically targeting cognitive function.
Exclusion criteria
Exclusion criteria: 1. Individuals with a diagnosis of severe cognitive impairment or dementia. 2. Participants with a history of significant neurological or psychiatric disorders other than mild cognitive impairment. 3. Individuals with a history of significant medical conditions that could affect cognitive function, such as stroke, traumatic brain injury, or untreated thyroid disorders. 4. Patients suffering with dyslipidaemia, ischemic heart disease, uncontrolled hypertensions and diabetes mellitus. 5. Participants with a history of substance abuse or alcohol dependence within the past year. 6. Individuals with a known allergy or hypersensitivity to any of the components of Saraswat Ghrita. 7. Participants currently enrolled in other clinical trials or studies involving investigational drugs or treatments. 8. Individuals with a history of significant gastrointestinal disorders or mal-absorption issues that may interfere with the absorption or metabolism of the study intervention. 9. Individuals who are unable or unwilling to comply with the study procedures and follow-up visits.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of feasibilityTimepoint: At baseline and end of 56 days treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in cognitive scores in MoCA scale, Changes in Quality of Life, Daily Functioning, Mood and Behavioural Symptoms, Safety Profile,Timepoint: At baseline and end of 56 days treatment | — |
Countries
India
Contacts
Public ContactDr Bharatkumar Padhar
National Institute of Ayurveda, Deemed to be University, Jaipur
Outcome results
None listed